Amid ongoing scrutiny of compounding pharmacies, a new analysis finds that state oversight has largely improved recently, although one glaring weakness is a cause for concern: Inspections are not being conducted as frequently as in the past.

Specifically, 32 states now require compounding pharmacies that make sterile medicines, which are injected or infused into the body, to fully comply with recognized quality standards, according to The Pew Charitable Trusts, a public policy organization. Two years ago, Pew conducted a similar analysis and found only 26 states had the same requirement.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy